- Home
- MYFW vs CCCC Comparison
MYFW vs CCCC Comparison
Compare MYFW & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- CCCC
- Stock Information
- Founded
- MYFW 2002
- CCCC 2015
- Country
- MYFW United States
- CCCC United States
- Employees
- MYFW N/A
- CCCC N/A
- Industry
- MYFW Major Banks
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- CCCC Health Care
- Exchange
- MYFW Nasdaq
- CCCC Nasdaq
- Market Cap
- MYFW 201.1M
- CCCC 175.1M
- IPO Year
- MYFW 2018
- CCCC 2020
- Fundamental
- Price
- MYFW $22.99
- CCCC $2.61
- Analyst Decision
- MYFW Buy
- CCCC Buy
- Analyst Count
- MYFW 2
- CCCC 2
- Target Price
- MYFW $24.25
- CCCC $8.00
- AVG Volume (30 Days)
- MYFW 46.3K
- CCCC 1.6M
- Earning Date
- MYFW 07-24-2025
- CCCC 08-07-2025
- Dividend Yield
- MYFW N/A
- CCCC N/A
- EPS Growth
- MYFW 226.95
- CCCC N/A
- EPS
- MYFW 1.18
- CCCC N/A
- Revenue
- MYFW $93,514,000.00
- CCCC $34,240,000.00
- Revenue This Year
- MYFW $14.41
- CCCC N/A
- Revenue Next Year
- MYFW $12.25
- CCCC N/A
- P/E Ratio
- MYFW $18.31
- CCCC N/A
- Revenue Growth
- MYFW 16.68
- CCCC 16.55
- 52 Week Low
- MYFW $16.77
- CCCC $1.09
- 52 Week High
- MYFW $24.88
- CCCC $7.22
- Technical
- Relative Strength Index (RSI)
- MYFW 61.39
- CCCC 59.15
- Support Level
- MYFW $21.35
- CCCC $2.47
- Resistance Level
- MYFW $21.96
- CCCC $3.07
- Average True Range (ATR)
- MYFW 0.70
- CCCC 0.29
- MACD
- MYFW 0.15
- CCCC 0.01
- Stochastic Oscillator
- MYFW 99.62
- CCCC 59.19
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.